National Institutes of Health (NIH): Partnerships for Structure-Based Design of Novel Immunogens for Vaccine Development (R01) 2016

This opportunity uses the R01 Research Project Grant funding mechanism.

This scheme aims to solicit applications from multi-disciplinary teams for milestone-driven research projects that utilise novel, structure-based vaccine design approaches to generate candidate vaccine immunogens against infectious disease pathogens of clinical concern.

Funding & Duration

Budgets for direct costs of up to US $750,000 (approx. AUD $1,034,000) per year may be requested.

Applicants may also request up to an additional US $300,000 (approx AUD $414,000) in the first year of the award for major equipment to ensure that research objectives can be met and biohazards can be contained, totaling US $1,050,000 (approx. AUD $1,448,000) direct costs.

The maximum project period is 5 years.


Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Submission Requirements & Due Dates

Further Information

This entry was posted in Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding, Sciences and tagged . Bookmark the permalink.

Comments are closed.